<DOC>
	<DOCNO>NCT00480571</DOCNO>
	<brief_summary>An open-label , multi-center , 6-week , sequential cohort study design determine safety tolerability two dose range BL-1020 hospitalize subject chronic schizophrenia schizo-affective disorder</brief_summary>
	<brief_title>Safety Tolerability BL-1020 Hospitalized Subjects With Chronic Schizophrenia Schizo-Affective Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<criteria>Male female 18 65 year age , inclusive meet criterion chronic ( diagnosis establish &gt; 1 year ago ) schizophrenia adequate psychotic symptom demonstrate PANSS total score &gt; 60 current diagnosis schizophrenia ( disorganized type , 295.10 ; catatonic type , 295.20 ; paranoid type , 295.30 ; undifferentiated type , 295.90 ) schizoaffective disorder ( 295.7 ) accordance DSMIV Agree fully hospitalize least Day 14 study Females must nonchildbearing potential : surgically sterilize ( i.e . tubal ligation ) , hysterectomy prior screen phase , postmenopausal . Females postmenopausal 12 month le 24 month must FSH &gt; 40 mU/mL . Pregnant lactate woman administration clozapine within 60 day prior Baseline DSMIV diagnosis schizophreniform disorder ( 295.40 ) schizophrenia residual subtype ( 295.60 ) , primary psychiatric diagnosis , bipolar disorder major depressive disorder Severity psychosis rat severe high ( CGIS 6 7 ) Known suicidal risk ( modify ISST score &gt; 7 ) Requiring disallow concomitant psychotropic medication follow enrolment study Current evidence clinically significant unstable illness Clinically significant abnormal laboratory data ( e.g . creatinine , AST ALT great 3 x upper limit normal , TSH &gt; 10 IU ) screening , abnormal laboratory value could interfere assessment safety ( e.g . blood cell count , etc . ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>chronic schizophrenia schizo-affective disorder</keyword>
</DOC>